logo Research, Innovation and Dissemination Centers

Center for Research on Inflammatory Diseases

CEPID 2013-2024 

Website: http://crid.fmrp.usp.br/

Principal investigator: Fernando de Queiroz Cunha
Education and knowledge diffusion coordinator: Rita de Cassia Aleixo Tostes Passaglia
Technology transfer coordinator: João Santana da Silva

HOST INSTITUTION
University of São Paulo (USP) 
Av. Bandeirantes, 3900
14049-900 - Ribeirão Preto, SP - Brasil
 
ASSOCIATED INSTITUTIONS
Oswaldo Cruz Foundation (FIOCRUZ) 

BV-FAPESP: research projects supported in this Center 


CRID in the Media: news about the Center

 

The Center for Research in Inflammatory Diseases (CRID) was created with the aim of producing integrative and translational scientific research to identify and validate new biological pathways involved in the induction and resolution of inflammation. To this end, it counts on the experience of researchers from various fields of Biomedical Sciences linked to basic research (genetics, molecular and cell biology, immunology, pharmacology, and pathology) and clinical research (rheumatology, immunology, infectology, and dermatology), in addition to researchers in the area of bioinformatics.

Inflammatory diseases constitute a complex and heterogeneous group of diseases that affect more than 10% of the world population. The treatment alternatives currently available are limited and, in some cases, ineffective, considering that information on the underlying mechanisms of the inflammatory process and the pathophysiology of inflammatory diseases is still lacking.

The specific objective of the Center is to advance knowledge about inflammatory diseases (infectious, autoimmune, and related to the cardiovascular system) to recognize and understand the molecular, immunological, pathological, and pharmacological mechanisms involved; identify new biological targets for the development of pharmacological therapeutic tools; search for possible diagnostic markers and prognostic indications, and apply new knowledge to design and synthesize molecules aimed at treating inflammatory diseases.

RESULTS OF RESEARCH CONDUCTED AT THE CENTER: